Literature DB >> 12125837

Improving mobility and community access in an adult with ataxia.

Glen Gillen1.   

Abstract

This case report summarizes the evaluation and treatment used to provide occupational therapy services to a man living with multiple sclerosis. Primary impairments included ataxia, paraparesis, and decreased endurance. The focus of this case study was on improving the client's ability to use powered mobility to access the community despite severe ataxia. A task-oriented approach was used as a frame of reference to guide the evaluation and intervention process. The primary goals of intervention were to control the degrees of freedom required for task participation and simultaneously increase postural stability, resulting in independent control of a power wheelchair. A combination of occupational therapy interventions is illustrated, including assistive technology, positioning, orthotic prescription, and adaptation of movement patterns.

Entities:  

Mesh:

Year:  2002        PMID: 12125837     DOI: 10.5014/ajot.56.4.462

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  4 in total

1.  Occupational therapy intervention to inspire self-efficacy in a patient with spinal ataxia and visual disturbance.

Authors:  Satsuki Tohyama; Fusako Usuki
Journal:  BMJ Case Rep       Date:  2015-02-09

2.  Power wheelchair driving challenges in the community: a users' perspective.

Authors:  Caryne Torkia; Denise Reid; Nicol Korner-Bitensky; Dahlia Kairy; Paula W Rushton; Louise Demers; Philippe S Archambault
Journal:  Disabil Rehabil Assist Technol       Date:  2014-03-18

3.  Use of cognitive aids and other assistive technology by individuals with multiple sclerosis.

Authors:  Kurt L Johnson; Alyssa M Bamer; Kathryn M Yorkston; Dagmar Amtmann
Journal:  Disabil Rehabil Assist Technol       Date:  2009-01

4.  Consensus paper: management of degenerative cerebellar disorders.

Authors:  W Ilg; A J Bastian; S Boesch; R G Burciu; P Celnik; J Claaßen; K Feil; R Kalla; I Miyai; W Nachbauer; L Schöls; M Strupp; M Synofzik; J Teufel; D Timmann
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.